The Relationship of Appetite-Regulating Hormones in the Development of Cardiac Cachexia
- PMID: 30799377
- DOI: 10.1536/ihj.18-131
The Relationship of Appetite-Regulating Hormones in the Development of Cardiac Cachexia
Abstract
The physiological control of appetite regulation involves circulating hormones with orexigenic (ghrelin) and anorexigenic (cholecystokinin) properties that induce alterations in energy intake via perceptions of hunger and satiety. We sought to investigate the relationship between appetite-regulating hormones and the cachexia associated with chronic heart failure.We randomized male Sprague-Dawley rats into myocardial infarction (MI) or sham operation (SO) groups. The levels of brain natriuretic peptide (BNP), cholecystokinin (CCK) and ghrelin in the plasma of all rats were detected by enzyme-linked immunosorbent assay (ELISA); the expression of BNP, CCK, and ghrelin in the myocardial tissue of all rats were detected by western blotting, immunohistochemistry, real-time polymerase chain reaction (PCR); myocardial morphology was assessed by microscopy.Plasma BNP and CCK levels in the cardiac cachexia (CC) groups and the heart failure non-cachexia (HF-nc) groups were significantly higher than those in the control groups (P < 0.01), and the expression of BNP and CCK in the myocardial tissue of rats: in CC groups and HF-nc groups were increased compared with the corresponding control groups (P < 0.01). In contrast, Plasma and cardiac expression of ghrelin decreased compared with the sham group (P < 0.01). Furthermore, plasma CCK levels were positively correlated with BNP concentrations (P < 0.001) and significantly negatively correlated with the ejection fraction (P < 0.001) in model animals; plasma ghrelin levels were negatively associated with BNP levels (P = 0.0023) and positively associated with ejection fraction (P = 0.0042).The appetite-regulating hormones (ghrelin and CCK) may present as a potential significant biomarker for cachexia associated with chronic heart failure.
Keywords: Cholecystokinin; Ghrelin; Heart failure; Myocardial infarction.
Similar articles
-
Cholecystokinin Expression in the Development of Postinfarction Heart Failure.Cell Physiol Biochem. 2017;43(6):2479-2488. doi: 10.1159/000484454. Epub 2017 Oct 31. Cell Physiol Biochem. 2017. PMID: 29130944
-
Cholecystokinin octapeptide reduces myocardial fibrosis and improves cardiac remodeling in post myocardial infarction rats.Int J Biochem Cell Biol. 2020 Aug;125:105793. doi: 10.1016/j.biocel.2020.105793. Epub 2020 Jun 15. Int J Biochem Cell Biol. 2020. PMID: 32554056
-
Ghrelin suppresses cardiac fibrosis of post-myocardial infarction heart failure rats by adjusting the activin A-follistatin imbalance.Peptides. 2018 Jan;99:27-35. doi: 10.1016/j.peptides.2017.10.018. Epub 2017 Nov 4. Peptides. 2018. PMID: 29113826
-
Effects of exercise intensity on plasma concentrations of appetite-regulating hormones: Potential mechanisms.Appetite. 2016 Mar 1;98:80-8. doi: 10.1016/j.appet.2015.12.016. Epub 2015 Dec 22. Appetite. 2016. PMID: 26721721 Review.
-
[Chronic heart failure and cachexia: role of endocrine system].Minerva Cardioangiol. 2011 Dec;59(6):601-12. Epub 2009 Nov 30. Minerva Cardioangiol. 2011. PMID: 19946251 Review. Italian.
Cited by
-
Experience and the nutritional relevance of protein-enriched ice cream in patients with heart failure - A pilot study.Heliyon. 2024 Jun 25;10(13):e33661. doi: 10.1016/j.heliyon.2024.e33661. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39040298 Free PMC article.
-
Cardiac Cachexia: A Well-Known but Challenging Complication of Heart Failure.Clin Interv Aging. 2020 Nov 2;15:2041-2051. doi: 10.2147/CIA.S273967. eCollection 2020. Clin Interv Aging. 2020. PMID: 33173285 Free PMC article. Review.
-
Cholecystokinin Expression in the Development of Myocardial Hypertrophy.Scanning. 2021 Aug 21;2021:8231559. doi: 10.1155/2021/8231559. eCollection 2021. Scanning. 2021. PMID: 34497680 Free PMC article.
-
Prognostic impact of cachexia by multi-assessment in older adults with heart failure: FRAGILE-HF cohort study.J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):2143-2151. doi: 10.1002/jcsm.13291. Epub 2023 Jul 11. J Cachexia Sarcopenia Muscle. 2023. PMID: 37434419 Free PMC article.
-
Early assessment and treatment of ventricular remodeling in vivo via a targeted ultrasonic molecular probe loaded with oxygen and cholecystokinin.J Nanobiotechnology. 2025 Feb 12;23(1):104. doi: 10.1186/s12951-025-03183-7. J Nanobiotechnology. 2025. PMID: 39939853 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous